Virtu Financial’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-5,119
Closed -$1.54M – 2119
2024
Q3
$1.54M Buy
+5,119
New +$1.57M 0.08% 182
2024
Q1
– Sell
-3,282
Closed -$1.16M – 2178
2023
Q4
$1.16M Buy
3,282
+1,130
+53% +$400K 0.09% 180
2023
Q3
$807K Buy
+2,152
New +$832K 0.08% 228
2023
Q2
– Sell
-1,187
Closed -$411K – 2105
2023
Q1
$411K Buy
+1,187
New +$347K 0.04% 415
2022
Q4
– Sell
-12,663
Closed -$3.12M – 2197
2022
Q3
$3.12M Buy
+12,663
New +$3.86M 0.29% 56
2021
Q4
– Sell
-713
Closed -$303K – 2232
2021
Q3
$303K Sell
713
-2,375
-77% -$1M 0.03% 709
2021
Q2
$1.11M Buy
3,088
+1,149
+59% +$380K 0.11% 175
2021
Q1
$546K Buy
+1,939
New +$555K 0.04% 481
2019
Q4
$623K Buy
4,146
+2,577
+164% +$375K 0.06% 344
2019
Q3
$223K Buy
+1,569
New +$216K 0.02% 906
2019
Q1
– Sell
-2,436
Closed -$239K – 1901
2018
Q4
$239K Buy
+2,436
New +$264K 0.01% 846
2018
Q2
– Sell
-6,136
Closed -$542K – 2559
2018
Q1
$542K Buy
+6,136
New +$574K 0.03% 667

Other funds holding WST

Virtu Financial's WST Position: Q4 2024 in Review

Virtu Financial sold out of West Pharmaceutical (WST) in Q4 2024, closing a stake of 5,119 shares — an estimated $1.54M sold.

Virtu Financial first reported a position in WST in Q1 2018 and held it in 12 quarters. The position peaked at $3.12M in Q3 2022. 748 funds tracked by Wall St. Rank hold WST as of Q4 2024.

  • Virtu Financial reported no remaining West Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Virtu Financial sold 5,119 West Pharmaceutical shares in Q4 2024, an estimated $1.54M.
  • Virtu Financial first reported a position in West Pharmaceutical in Q1 2018 and held it in 12 quarters.
  • Virtu Financial's West Pharmaceutical position peaked at $3.12M in Q3 2022.
  • 748 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.